Not exact matches
«This investigational single tablet regimen brings together the potency of an integrase inhibitor, bictegravir, with the
demonstrated efficacy and safety profile of the FTC / TAF backbone,» said Norbert Bischofberger, executive vice president,
research and development and chief scientific
officer, Gilead Sciences.
«RBC GAM's investment approach is characterized by fundamental
research and rigorous discipline, along with a focus on risk management and portfolio construction, all within a team - oriented structure,» said Dan Chornous, chief investment
officer, RBC Global Asset Management Inc. «Habib and his team fit seamlessly with our approach, as
demonstrated by their strong investment results and stability of returns, with notably solid performance in down markets.»
Christophe Quéva, chief scientific
officer, commented «The building of a custom designed R&D facility
demonstrates our commitment to our cancer immunology
research programs and will enable us to recruit additional qualified scientists needed in both our drug discovery and development.»